Oncolytics Biotech Inc.

NASDAQ:ONCY

1.12 (USD) • At close May 20, 2024
Bedrijfsnaam Oncolytics Biotech Inc.
Symbool ONCY
Munteenheid USD
Prijs 1.12
Beurswaarde 84,470,176
Dividendpercentage 0%
52-weken bereik 0.88 - 3.39
Industrie Biotechnology
Sector Healthcare
CEO Dr. Matthew C. Coffey M.B.A., Ph.D.
Website https://www.oncolyticsbiotech.com

An error occurred while fetching data.

Over Oncolytics Biotech Inc.

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA

Vergelijkbare Aandelen

Qilian International Holding Group Limited logo

Qilian International Holding Group Limited

QLI

0.661 USD

Bolt Biotherapeutics, Inc. logo

Bolt Biotherapeutics, Inc.

BOLT

0.79 USD

SCYNEXIS, Inc. logo

SCYNEXIS, Inc.

SCYX

2.62 USD

Seelos Therapeutics, Inc. logo

Seelos Therapeutics, Inc.

SEEL

1.745 USD

Entera Bio Ltd. logo

Entera Bio Ltd.

ENTX

2.3 USD

Bionomics Limited logo

Bionomics Limited

BNOX

0.917 USD

Rain Therapeutics Inc. logo

Rain Therapeutics Inc.

RAIN

1.21 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)